Aaliyah Eaves, JD, LLM, PhD, HEC-C
Adjunct Assistant Professor at University of Louisville School of Public Health and Information Sciences
University of Louisville School of Public Health and Information Sciences
https://www.linkedin.com/company/ulsphis
Adjunct Assistant Professor
Department of Health Management and Systems Sciences
https://media-exp1.licdn.com/dms/image/C510BAQFuCiKOGVGOxA/company-logo_100_100/0/1519906358537?e=1655942400&v=beta&t=JoqfPBynTKRjR3Yf-6FsaOEvv3GMl9JNZ1C-0OGPaxY
Dinsmore & Shohl LLP
https://www.linkedin.com/company/dinsmore-&-shohl-llp
Partner: Healthcare Practice Group (Life Sciences)
Life Sciences regulatory attorney and bioethics consultant helping clients strategically traverse ethically fraught complex business decisions with significant liability implications. Responsible for providing precise and effective legal analysis for healthcare providers and clients developing new technologies in an evolving and highly regulated healthcare industry.
Louisville, Kentucky Area
https://media-exp1.licdn.com/dms/image/C4E0BAQGlIwUCxNHQIg/company-logo_100_100/0/1519856605482?e=1655942400&v=beta&t=pY0D1DHSODFA3dbp5ifBduB-qbXXyvC60ChwtFyvyPc
American Board of Medical Specialties (ABMS), Ethics and Professionalism Committee
Committee Member
Chicago, Illinois, United States
US Army
https://www.linkedin.com/company/us-army
Healthcare Resolutions Specialist
Creative problem-solver and skilled negotiator of legal disputes, healthcare conflicts and complex crosscutting policy decisions. Responsible for delivering healthcare resolution services, investigative reviews, compliance audits, medical error disclosure and adverse event mediation/negotiation with patients and clinical staff, ethics consultations and professional development training to faculty and staff at US Department of Defense medical treatment facilities in Europe.
Landstuhl Regional Medical Center, Landstuhl, Germany
https://media-exp1.licdn.com/dms/image/C4D0BAQHs7WhQTJ7GTQ/company-logo_100_100/0/1519856313202?e=1655942400&v=beta&t=bXjUfpYuR9GBCKq9thMIMaWA-cZYo0C3oUvIp9soT2o
FDA
https://www.linkedin.com/company/fda
Policy Advisor: Office of the Center Director, Center for Devices and Radiological Health
Experienced advisor on national and international regulatory rules and policies. Liaison responding to substantive and procedural questions from industry and staff related to agency oversight, clinical research, legal liability, policy development and ethics issues. Responsible for providing cogent and timely regulatory guidance as a senior level policy advisor and bioethics consultant in the Center for Devices and Radiological Health (CDRH), Office of the Center Director (OCD).
Washington D.C. Metro Area
https://media-exp1.licdn.com/dms/image/C510BAQG-r6vVscIc1g/company-logo_100_100/0/1519855864399?e=1655942400&v=beta&t=BVOgpwZgvJ_WeZQreKkztYq8GYIe9FoNXYaDvIBXxtY
U.S. Department of Veterans Affairs
https://www.linkedin.com/company/department-of-veterans-affairs
Risk Management & Patient Advocate Program Manager
Collaborative change-agent guiding patient safety projects and leading risk mitigation programs. Responsible for managing the medical center Risk Management and Patient Advocate Programs for the Quality, Patient Safety and Risk Office at a large tertiary care research medical center. Co-Investigator for $2.45M adverse event disclosure program training grant.
Lexington, Kentucky Area
https://media-exp1.licdn.com/dms/image/C560BAQGsl_8G72scfw/company-logo_100_100/0/1519856373324?e=1655942400&v=beta&t=JONKpuxU8OL76kq0ec8i69AKyoCWs-enu4VrG8N0exA
Jefferson County Attorney's Office
https://www.linkedin.com/company/jeffcocolorado
Assistant County Attorney
Represented the Commonwealth of Kentucky and successfully prosecuted criminal cases in Jefferson County District Court. Created an effective and efficient case management system that significantly improved convictions.  Achieved the first 100% conviction rate for the office.
Louisville, Kentucky Area
https://media-exp1.licdn.com/dms/image/C4E0BAQFUddBtiJnWAg/company-logo_100_100/0/1519856050133?e=1655942400&v=beta&t=L__Y1gGPUHf_PbKyv4jbh_t6Q3aDvMNkUrTle7q4BAg
Franklin and Hance, P.S.C
Law Clerk
Provided legal assistance for named partner in a busy medical malpractice and personal injury litigation law firm.  Contributed legal research, analysis and appellate pleadings and motions to defend a verdict in a complex pharmaceutical product liability case.
Louisville, Kentucky Area
Doctor of Philosophy – PhD
Saint Louis University
https://www.linkedin.com/school/saint-louis-university/
https://media-exp1.licdn.com/dms/image/C560BAQEreJCyw0qtHQ/company-logo_100_100/0/1519889478847?e=1655942400&v=beta&t=stq5llUZ3kRS3Bl0D2ZtdiKIdIMllejNg92pHEFY3Kk
JD
University of Kentucky J. David Rosenberg College of Law
LLM
Indiana University Robert H. McKinney School of Law
BFA
Carnegie Mellon University
https://www.linkedin.com/school/carnegie-mellon-university/
https://media-exp1.licdn.com/dms/image/C4E0BAQHuB0Kghi5Syw/company-logo_100_100/0/1574428478747?e=1655942400&v=beta&t=Ihqh1iu5PaROiDXpeWUQlbZWYhrNzS4tN3d89Cr7Bkc
Using plasma from recovered COVID-19 patients
Medical News
Given the recent FDA guidance for investigational studies using plasma from recovered COVID-19 patients (issued September 2, 2020), some healthcare networks are considering asking recovered patients to donate their plasma. Legal and ethical concerns have been raised about the appropriateness of asking patients to take on additional risk when the proposed treatment has uncertain benefits. Amid muddled politician messaging about what works against COVID-19, some urge a cautious approach. They worry official institutional promotion of experimental treatments may later be disproven and seriously undermine public trust in proven interventions, such as a vaccine.  Ethicists worry about the possibility of therapeutic misconception or biases that impact outcomes given the crises conditions that justify emergency authorization for the use of unproven therapies.

These are essential legal and ethical questions to consider before implementing a policy for COVID-19 convalescent plasma.
http://www.medicalnews.md/using-plasma-from-recovered-covid-19-patients/
FDA Warns Consumers to Stop Using THC Vaping Products Amid Ongoing Investigation into Lung Injuries
Dinsmore & Shohl LLP
Legal Alert
https://www.dinsmore.com/publications/fda-warns-consumers-to-stop-using-thc-vaping-products-amid-ongoing-investigation-into-lung-injuries/
Confronting Ethical and Regulatory Challenges of Emergency Care Research with Conscious Patients
ANN EMERG MED
Barriers to informed consent are ubiquitous in the conduct of emergency care research across a wide range of conditions and clinical contexts. They are largely unavoidable; can be related to time constraints, physical symptoms, emotional stress, and cognitive impairment; and affect patients and surrogates. US regulations permit an exception from informed consent for certain clinical trials in emergency settings, but these regulations have generally been used to facilitate trials in which patients are unconscious and no surrogate is available. Most emergency care research, however, involves conscious patients, and surrogates are often available. Unfortunately, there is neither clear regulatory guidance nor established ethical standards in regard to consent in these settings. In this report-the result of a workshop convened by the National Institutes of Health Office of Emergency Care Research and Department of Bioethics to address ethical challenges in emergency care research-we clarify potential gaps in ethical understanding and federal regulations about research in emergency care in which limited involvement of patients or surrogates in enrollment decisions is possible. We propose a spectrum of approaches directed toward realistic ethical goals and a research and policy agenda for addressing these issues to facilitate clinical research necessary to improve emergency care.
DOI: 10.1016/j.annemergmed.2015.10.026
https://www.annemergmed.com/article/S0196-0644(15)01425-0/fulltext
Open Disclosure of Adverse Events: Transparency and Safety in Health Care
SURG. CLIN. N. AM
Many patients suffering adverse events in health care turn to the legal system to learn what happened to them and to seek compensation. Health care providers have ethical, professional, and legal duties to disclose the harmful effects of care to the patient, regardless of how small the risk. The purpose of open disclosure is to explain what happened to the patient and to seek a just outcome for patient and provider. This article explores our experience of managing and implementing an open disclosure program in an acute and chronic tertiary care facility with university affiliation in the Veterans Health Administration.
DOI: 10.1016/j.suc.2011.11.001
https://www.sciencedirect.com/science/article/pii/S0039610911001496?via%3Dihub
https://www.linkedin.com/in/dan-zinsmaster-88b8436
Dan Zinsmaster
Partner at Dinsmore & Shohl LLP
Columbus, OH
https://www.linkedin.com/in/karen-gaunt-79264214
Karen Gaunt
Partner, Director of Trademark, Copyright & Brand Strategies Group at Dinsmore & Shohl LLP
Cincinnati, OH
https://www.linkedin.com/in/kelsey-haught-parsons-0a5b19101
Kelsey Haught Parsons
Labor and Employment Attorney at Dinsmore & Shohl LLP
South Charleston, WV
https://www.linkedin.com/in/randy-roach-89958814
Randy Roach
Partner, Roach Newton LLP & Adj Prof Appellate Law UT&UH
Houston, TX
https://www.linkedin.com/in/christiane-ayesse-8a49091b8
Christiane Ayesse
--
Orlando, FL
https://www.linkedin.com/in/amber-kean-9741b355
Amber Kean
Shelby County Schools Teacher
Memphis, TN
https://www.linkedin.com/in/anita-ho-4804835a
Anita Ho
Bioethicist and Health Services/Policy Researcher
United States
https://www.linkedin.com/in/bethroxland
Beth E. Roxland J.D., M.Bioethics
Strategic Advisor on Law, Policy & Bioethics | Pandemic & Vaccine Policy | Stem Cell, Regenerative Medicine and Gene Therapies | Clinical Trials & Industry Ethics
New York, NY
https://www.linkedin.com/in/lisa-langford-ba16758
Lisa Langford
Attorney at Louisville Metro Government
Prospect, KY
https://www.linkedin.com/in/daniel-sulmasy-68a99a156
Daniel Sulmasy
Hellegers Professor of Biomedical Ethics, Georgetown University; Director, Kennedy Institute at Georgetown University
Washington, DC
https://www.linkedin.com/in/ann-langford-3353693b
Ann Langford
--
United States
https://www.linkedin.com/in/barbara-unseld-0033b531
Barbara Unseld
Retired Educator
United States
https://ca.linkedin.com/in/louis-sutker-71a30917
Louis Sutker
Interim Rabbi
Victoria, BC
https://www.linkedin.com/in/jerry-eaves-6932608a
Jerry Eaves
Sports Professional
Greensboro, NC
https://www.linkedin.com/in/camlowellmatthews
Cameron Matthews
Seeking license to become Customs Broker
Prospect, KY
https://www.linkedin.com/in/anne-cecile-baer-porter-b03104aa
Anne-Cecile Baer Porter
Staff Chaplain with Multicare
Tacoma, WA
https://www.linkedin.com/in/alex-kalter-64367736
Alex Kalter
Intellectual Property Counsel at SHINE Technologies
United States
https://www.linkedin.com/in/bernadette-ayesse-3a5655140
Bernadette Ayesse
Student at University of Central Florida
Orlando, FL
https://www.linkedin.com/in/nico-nortje-phd-497884181
Nico Nortje, PhD
Director for Goals of Care and End-of-Life; 
Clinical Ethicist; 
Assistant Professor - Univ of Texas MD Anderson Cancer Center
Houston, TX
https://www.linkedin.com/in/ivan-mayerhofer-1767595
Ivan Mayerhofer
Associate Chaplain for Buddhist Programs, Director of the Meditation Initiative, and Coordinator of Interfaith Programs at Davidson College
Cornelius, NC